Cancer Linkage With an HIV/STD Registry: Describing the Cancer Morbidity Among HIV/AIDS Patients and Opportunities for Improving Surveillance June 5, 2007.

Slides:



Advertisements
Similar presentations
Impact of Age and Race on New HIV Infections among Men who have Sex with Men in Los Angeles County Shoshanna Nakelsky, MPH Division of HIV and.
Advertisements

Estimating the number of Kentuckians living with HIV disease with unmet needs for HIV-related primary care in calendar year 2010  Reducing new HIV infections.
Florida Department of Health HIV/AIDS Section Division of Disease Control and Health Protection Annual data trends as of 12/31/2013 Living (Prevalence)
Syphilis Trends in the United States James D. Heffelfinger, MD, MPH Epidemiology and Surveillance Branch, DSTD Centers for Disease Control and Prevention.
Mortality and causes of death among women living with HIV in the UK in the era of highly-active antiretroviral therapy Sara Croxford, A Kitching, M Kall,
HIV/AIDS AMONG LATINOS IN NEW JERSEY presented by: Gloria M. Rodriguez, DSW Assistant Commissioner Division of AIDS Prevention and Control presented at.
HIV Care Continuum, Men Who Have Sex with Men Only (MSMO) and Men Who Have Sex with Men and Women (MSMW), Georgia, 2012.
HIV Infection in Michigan January 1, 2012 Michigan Department of Community Health HIV/STD/VH/TB Epidemiology Section Division of Communicable Diseases.
HIV/AIDS Prevalence & Mortality Report, 2010 Minnesota Department of Health HIV/AIDS Surveillance System Minnesota Department of Health HIV/AIDS Surveillance.
Tuesday, June 23, Today’s discussion General cancer statistics Cancer in Canada PEI Statistics at a glance Impact.
HIV/AIDS Prevalence & Mortality Report, 2001 Minnesota Department of Health HIV/AIDS Surveillance System Minnesota Department of Health HIV/AIDS Surveillance.
The Internet: An Emerging Venue for Syphilis Epidemics Among Men Who Have Sex with Men in Los Angeles LAC - DHS Getahun Aynalem, MD, MPH, Kellie Hawkins,
HIV/AIDS Prevention Committee Public Meeting November 21, 2013.
1 HIV/STD Trends in Texas Sharon K. Melville, M.D., M.P.H. Texas Department of State Health Services Texas Public Health Association April 22, 2010.
Linking STD and HIV Morbidity and Risk Behaviors in Indiana James D. Beall, MA Sr. Public Health Advisor Indiana State Department of Health.
Emerging Trends of HIV/AIDS in New York City Chris Williams, MPH NYC DOHMH.
HIV Infection Among Those with an Injection Drug Use*- Associated Risk, Florida, 2012 Florida Department of Health HIV/AIDS and Hepatitis Section Division.
Routine HIV Screening in Health Care Settings David Spach, MD Clinical Director Northwest AIDS Education and Training Center Professor of Medicine, Division.
Epidemiology of HIV among Asians & Pacific Islanders Reported in Florida, Through 2012 Florida Department of Health HIV/AIDS and Hepatitis Section Annual.
Epidemiology of HIV Among Asians and Pacific Islanders Reported in Florida, Through 2014 Florida Department of Health HIV/AIDS Section Division of Disease.
HIV Surveillance Report, 2012 Minnesota Department of Health HIV/AIDS Surveillance System Minnesota Department of Health HIV/AIDS Surveillance System.
HIV/STD Epidemiology in Oklahoma HIV/STD Service Division of Prevention and Preparedness Oklahoma State Department of Health.
MOLLY SCHWENN, MD CANCER REGISTRY MAINE CDC, DHHS OCTOBER 25, 2013 Population-based Cancer Surveillance: State Perspective.
Epidemiology of Oral Cancer Module 1:. Epidemiology of Cancer, U.S.
Causes of Death and Mortality Trends among Utah HIV/AIDS Cases, Anne Burke, MS, Matthew S. Mietchen, MPH, David Jackson, MPH, Allyn K. Nakashima,
Using Phylogenetic Analysis to Identify HIV Transmission Channels among Persons Newly Diagnosed with HIV-1 Infection in Los Angeles County, Kwa.
* For those free of cancer at beginning of age interval. Source: DevCan: Probability of Developing or Dying of Cancer Software, Version Statistical.
Centers for Disease Control and Prevention CDC Half-Year of Diagnosis** Number of Cases **Adjusted for reporting delay AIDS Cases in Racial/Ethnic Minorities*
Health Consultation: Evaluation of Cancer Incidence in Census Tracts of Attleboro and Norton, Massachusetts: Suzanne K. Condon Associate Commissioner.
Epidemiology of HIV Among Hispanics Reported in Florida, Through 2012 Florida Department of Health HIV/AIDS and Hepatitis Section Division of Disease Control.
Racial Disparities in Antiretroviral Therapy Use and Viral Suppression among Sexually Active HIV-infected Men who have Sex with Men— United States, Medical.
Wisconsin Department of Health Services HIV/AIDS Surveillance Annual Review New diagnoses, prevalent cases, and deaths through December 31, 2013 April.
INCIDENCE AND SURVIVAL TRENDS OF COLORECTAL CANCER FROM 2002 TO 2011 BE Ansa; E Alema-Mensah; MD Claridy; JQ Sheats; B Fontenot, and SA Smith Georgia Regents.
HIV Care Continuum, District 8- 2 Southwest (Albany), Georgia, 2012.
HIV/AIDS among Women in Texas Enhanced Perinatal Surveillance May 30, 2007 Nita Ngo, MPH.
Nguyen ML, Sumbry A, Reddy D, Harvey K, Gunthel C, Wang W, Tsui C, Ziemer D, del Rio C, Young JL Increased Incidence of Non AIDS-related Malignancies and.
ABSTRACT Background: In late 2003, a group of Centers for Disease Control and Prevention/National Program of Cancer Registries (CDC/NPCR) staff and faculty/staff.
Epidemiology Applications Fran C. Wheeler, Ph.D School of Public Health University of South Carolina Columbia, SC (803)
Quarterly HIV/AIDS Analysis for Michigan July 1, 2006 Michigan Department of Community Health HIV/STD & Other Bloodborne Infections Surveillance Section.
HIV Care Continuum, Georgia, United States, 2011 Presented to American Public Health Association, Annual Meeting Presented by Deepali Rane, MBBS, MPH,
Florida Department of Health HIV/AIDS and Hepatitis Section Division of Disease Control and Health Protection Annual data trends as of 12/31/2012 Living.
HIV Disease and Hepatitis C Virus (HCV) Co-Infection – Florida, 2011 HIV/AIDS & Hepatitis Program - Surveillance Section HIV Disease data from 1981 through.
Lipoatrophy and lipohypertrophy are independently associated with hypertension: the effect of lipoatrophy but not lipohypertrophy on hypertension is independent.
Adolescent and Young Adult Oncology Scientific Meeting 2013 Epidemiology Working Group.
HIV Care Continuum New Diagnoses, 2011, Fulton County, Georgia.
HIV Care Continuum, District 10 Northeast (Athens), Georgia, 2012.
Monitoring Indicators of the National HIV/AIDS Strategy Using Data for Public Health Action Irene Hall, PhD, FACE HIV Incidence and Case Surveillance Branch.
HIV Care Continuum Persons Living With HIV, Georgia, 2012.
Tools to Access the Latest Cancer Statistics Paul Miller Washington Reporting Fellowships program presentation April 15, 2013.
SOUTH CAROLINA EPIDEMIOLOGIC PROFILE What is the Epi Profile? The HIV/AIDS Epidemiologic Profile is a document that: Describes the HIV/AIDS epidemic.
HIV/AIDS Prevalence & Mortality Report, 2012 Minnesota Department of Health HIV/AIDS Surveillance System Minnesota Department of Health HIV/AIDS Surveillance.
The Continuum of HIV Care Florida, 2014 The Continuum of HIV Care Florida, 2014 Lorene Maddox, MPH Karalee Poschman, MPH Living data through 2014, as of.
Epidemiology of HIV Infection Trends Among Adults Living in Rural and Non-Rural Counties in Florida (excl DOC*) Diagnosed through 2014 Created:12/04/14.
Florida Department of Health HIV/AIDS Section Division of Disease Control and Health Protection Annual data trends as of 12/31/2014 Living (Prevalence)
Florida Department of Health HIV/AIDS and Hepatitis Section Division of Disease Control and Health Protection Annual data trends as of 12/31/2012 Living.
Florida Department of Health HIV/AIDS & Hepatitis Program Annual data trends as of 12/31/2011 Living (Prevalence) data as of 05/16/2012 Epidemiology of.
SEER Data Cancer Project Brett Langsjoen. SEER Surveillance, Epidemiology, and End Results Program of the National Cancer Institute (NCI) Purpose: Collect.
Chicago Department of Public Health Richard M. Daley Mayor Bechara Choucair, MD Commissioner CDPH – STI/HIV Surveillance, Epidemiology and Research Section.
HIV Care Continuum New Diagnoses, 2011, Georgia. Persons with HIV Engaged in Selected Stages of the Continuum of Care, United States Percent
Quarterly HIV/AIDS Analysis for Michigan January 1, 2007 Michigan Department of Community Health HIV/STD & Other Bloodborne Infections Surveillance Section.
Viral load distribution 2012 among persons living with HIV and persons newly diagnosed Georgia, 2011.
Epidemiology of HIV Among Asians and Pacific Islanders Reported in Florida, Through 2012 Florida Department of Health HIV/AIDS and Hepatitis Section Division.
Slideset on: Patel P, Hanson DL, Sullivan PS, et al. Incidence of types of cancer among HIV-infected persons compared with the general population in the.
Meg Watson, MPH Recent Trends in HPV-Associated Cancers among Women Epidemiology and Applied Research Branch Division of Cancer Prevention and Control.
Problems of HIV Infection in the HAART Era Akihiko Suganuma M.D. Tokyo Metropolitan Komagome Hospital Department of Infectious Diseases.
Cancer Facts MS JYOTI SHAH CONSULTANT UROLOGICAL SURGEON SOURCE: CANCER RESEARCH UK.
Bronx Community Health Dashboard: Other Cancers Last Updated: 01/09/2018 See last slide for more information about this project.
San Francisco Department of Public Health
Estimated current cancer incidence
Recent Incidences and Trends of the Top Cancers in Northeast Tennessee Appalachian Region Adekunle Oke1, Sylvester Orimaye2, Ndukwe Kalu1, Dr. Faustine.
Presentation transcript:

Cancer Linkage With an HIV/STD Registry: Describing the Cancer Morbidity Among HIV/AIDS Patients and Opportunities for Improving Surveillance June 5, 2007 Jennifer Chase, MSPH Texas HIV/STD Epidemiology and Surveillance Branch Melanie Williams, PhD Cancer Epidemiology and Surveillance Branch Nancy Weiss, PhD Cancer Epidemiology and Surveillance Branch Tammy Sajak, MPH Texas HIV/STD Epidemiology and Surveillance Branch Paul Betts, MS Cancer Epidemiology and Surveillance Branch

Acknowledgements  National Cancer Institute Eric Engels, MD, MPH Phillip W. Virgo  HIV/STD Epidemiology and Surveillance Branch Barry Mitchell, MPH Sharon Melville, MD, MPH

Outline  Background  HIV/AIDS – Cancer Match –Overview –Findings  Next Steps  Lessons Learned

Background  Match was performed in collaboration with the Viral Epidemiology Branch National Cancer Institute (NCI), the Texas Cancer Epidemiology and Surveillance Branch, and Texas HIV/STD Epidemiology and Surveillance Branch  Comprehensively matched the Texas Cancer and HIV/AIDS Registries for the first time as part of the NCI, “Cancer HIV/AIDS Match Study”

Background  People with HIV and AIDS are at high risk for developing certain cancers  “AIDS-defining” cancers for HIV-infected –Kaposi Sarcoma –Non-Hodgkin’s Lymphoma –Invasive Cervical Cancer  Other types of cancer also appear to be more common among persons with persons with AIDS (PWAs)

Background Non-AIDS Defining Cancers  Some non-AIDS defining cancers have been found to occur in excess among PWAs –Pancreatic –Laryngeal –Heart (usually melanomas and sarcomas) –Vulva –Vaginal –Kidney –Penile –Soft tissues –Hodgkin’s lymphoma –Anal –Multiple Myeloma –Leukemia –Lung –Oral cavity –Lip –Esophageal –Stomach –Liver

Background HAART and Cancer  Highly Active Antiretroviral Therapy (HAART) introduced in Mid 1990s  Reductions in some AIDS-defining cancers –Kaposi Sarcoma: dramatic declines –Non-Hodgkin’s Lymphoma: Effect of HAART not clear, some studies show decline –Invasive Cervical Cancer: Studies have been conflicting

Background HAART and Cancer  PWAs living longer and sustaining fewer opportunistic infections making cancer a more prominent cause of death –Pre-HAART, 10% of deaths from cancer –Year 2000, 28% from cancer

HIV/AIDS Cancer Match Study  Purpose: To link HIV/AIDS registries to cancer registries in multiple sites in the US that represent the major epicenters of the HIV/AIDS epidemic, including Texas (NY, MA, NJ, IL, FL, City of NY, Los Angeles, San Francisco, Seattle, San Diego, Atlanta)  Expect 40,000-50,000 cancer cases among 500,000 persons with AIDS  Diversity of geography, HIV risk groups, and racial/ethnic minorities

HIV/AIDS Cancer Match Study  Objectives: –To monitor cancer incidence in persons with HIV and AIDS –Determine risk of cancer among persons with HIV/AIDS –Determine which factors may be predictive among persons with HIV/AIDS –Determine if cancers in persons with HIV/AIDS differ from cancers among the general population –To increase communication between the local HIV/AIDS and cancer registries to enhance surveillance

HIV/AIDS Cancer Match Study  Typically, only 1/3 of AIDS related cancers are recorded in both registries  Non-AIDS-related cancers are not reported to HIV/AIDS registries, but cancer registries collect them  HIV/AIDS related data are not collected by cancer registries  Other data may be missing on one registry and found in another, such as dates of birth or death that can provide a more complete research file

Texas Match Overview Cancer Registry Cases Included: 744,160 cases Texas residents, diagnosed from HIV/AIDS Registry Cases Included: 93,120 HIV positive only and HIV/AIDS cases Texas residents, diagnosed from 1980-March 2006

Analysis Overview Included: –Cancer Diagnoses Cancers diagnosed with +/- 5 years of AIDS diagnosis Invasive tumors only –AIDS cases years of age Diagnosed with AIDS /2006 Alive for at least one month in

Match Overview  Records were linked by computer using commercial probabalistic matching software  Match based on name, date of birth, social security number, race, sex, date of death, and residential information  Both cancer and HIV/AIDS files blinded from NCI researchers

Match Overview  Software takes data common to both registries –Defines the distribution of the identifying variables –Attributes probability scores to the likelihood of matches on these variables being found by chance, and sums the scores –Results in score that indicates the strength of the match between records in the two registries –So fields like sex have little variability and add little to the match –SSN is virtually unique though and can indicate a high probability of a match, unless there is an error in the SSN –Allows some latitude for errors (like name misspelling) and ignores missing data

Completeness of Texas Data Elements PercentComplete Data ElementHIV/AIDS RegistryCancer Registry Name100% Date of Birth99% SSN76%98% Race98% Sex99%

Match Overview  Overall, 2,547 AIDS cases (n=46,004) had at least one cancer diagnosed during the +/- 5 year time period ( )  Identified 1,006 (72%, n=1,388) Texas Kaposi Sarcoma cases diagnosed from were not in the Texas HIV/AIDS Registry  Identified 321 “presumptive” and 110 “definitive” Kaposi Sarcoma cases not in the Texas Cancer Registry  Identified 151 non-Hodgkin’s Lymphoma cases not in the Texas Cancer Registry, diagnosed from (n=17,098)

Demographic Characteristics Among People Included in AIDS-Cancer Match All Cancer Cases N=744,160 All AIDS Cases N=46,004 Developed Cancer N=2,574 Male51%82%89% Median Age at AIDS Dx Median Age at CancerDx 66-- Non-Hisp White73%39%48% Non-Hisp Black10%36%26% Hispanic14%24%26%

All AIDS cases N=46,004 Developed Cancer N=2,574 Men who have Sex with Men* 57%67% Injection Drug Use16%11% Heterosexual14%10% Blood Transfusion<1% Other/Unk12% HIV Transmission Risk Among People Included in AIDS-Cancer Match *includes MSM and IDU

Standardized Incidence Ratio  Standardized incidence ratios (SIR) were calculated to com  Compare cancer rates among PWAs to rates among the general population of Texas Standardized Incidence Ratio (SIR) = Observed # of cancer cases in AIDS population Expected # of cancer cases in the general Texas population

ObsExpSIR (95% CI) Male ( ) Female ( ) Overall ( ) AIDS-Defining Cancers Kaposi Sarcoma

ObsExpSIR (95% CI) Male ( ) Female ( ) Overall ( ) AIDS-Defining Cancers Non-Hodgkin’s Lymphoma

Kaposi Sarcoma Non-Hodgkin’s Lymphoma SIR (95% CI) Men who have Sex with Men* ( )43.2 ( ) Heterosexual 66.6 ( )29.8 ( ) Injection Drug Use 50.8 ( )24.1 ( ) Kaposi Sarcoma and Non-Hodgkin’s Lymphoma by Transmission Risk *includes MSM and IDU

ObsExpSIR (95% CI) Female ( ) AIDS-defining cancers Invasive Cervical Cancer

Non-AIDS Defining Cancers –Lymphocytic Leukemia –Melanoma of the Skin –Myeloid and Monocytic Leukemia –Myeloma –Pancreatic –Prostate –Rectal –Stomach –Testis –Thyroid –Tongue –Tonsil –Anal –Bladder –Breast –Brain –Colon –Esophageal –Gum and Other Mouth –Hodgkin’s Lymphoma –Kidney –Laryngeal –Lip –Liver –Lung  Calculated SIRs for 25 non-AIDS defining cancers with >4 observed cases

Findings  Of the 25 non-AIDS defining cancers –14 no significant difference between observed and expected cases –10 significantly higher –1 significantly lower

ObsExpSIR (95% CI) Anal ( ) Hodgkin’s Lymphoma ( ) Lip ( ) Myeloma ( ) Tonsil ( ) Non-AIDS-Defining Cancer Excess in Texas PWAs

ObsExpSIR (95% CI) Lung ( ) Liver ( ) Lymphocytic Leukemia ( ) Rectal ( ) Melanoma ( ) Non-AIDS-Defining Cancer Excess in Texas PWAs

Non-AIDS-Defining Cancer Lower in Texas PWAs ObsExpSIR (95% CI) Prostate ( )

ObsExpSIR (95% CI) Men who have Sex with Men* ( ) Heterosexual ( ) Injection Drug Use ( ) Other/Unk ( ) Anal Cancer by Transmission Risk *includes MSM and IDU

ObsExpSIR (95% CI) Men who have Sex with Men* ( ) Injection Drug Use ( ) Liver and IHB Cancer by Transmission Risk *includes MSM and IDU

ObsExpSIR (95% CI) Men who have Sex with Men* ( ) Heterosexual ( ) Injection Drug Use ( ) Other/Unk ( ) Lung Cancer by Transmission Risk *includes MSM and IDU

Summary  Kaposi’s Sarcoma (n=871) and Non-Hodgkin’s Lymphoma (n=929) represented the majority of cancers found in this cohort  All of the AIDS defining cancers were found to be in excess as expected  10 non-AIDS defining cancers were found in excess in the Texas AIDS population, 9 of these have risk factors involving infectious agents, suppressed immune systems, and/or tobacco use  Cancers associated with HPV infection, immuno- suppression, and tobacco use appear to be a particular problem in the HIV/AIDS community

Next Steps  Utilize linkage to improve both HIV/AIDS and cancer surveillance  Examine cd4 counts/immunosuppression in relation to cancer diagnoses  Examine geographical differences  Re-match every 3-4 years  Explore long-term use of HAART on changes in cancer incidence  Utilize data to inform prevention and service activities

Lessons Learned  Use the linkage as an opportunity to enhance registry data quality and future linkages  Do homework/receive background documentation on what makes a case in one registry versus the other, national data standards, and procedures/practices that can affect linkage and/or interpretation of results  If the registries are in agreement that linkage files can be shared between them, each receive the same files  Ensure that data sharing between registries is spelled out in detail in IRB request and/or MOU

For Additional Information Contact: Melanie Williams, Ph.D. Senior Epidemiologist Texas Cancer Registry, Department of State Health Services (DSHS) Phone: ext